This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984
Title: Akira Kagemoto: Innovator in Valproic Acid Determination
Introduction
Akira Kagemoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the determination of valproic acid. His innovative work has implications for immunoassays and antibody production.
Latest Patents
Kagemoto holds a patent for a method that involves the determination of valproic acid and its reagents. The patent, titled "Method for determination of the valproic acid and reagents therein," introduces .delta.-substituted derivatives of valproic acid for conjugation to antigenic compositions, especially proteins and enzymes. These antigenic conjugates are utilized in the production of antibodies, which are essential for immunoassays aimed at determining valproate levels. Additionally, the patent describes a kit that includes the conjugate and the antibody, along with a method for determining valproate using this kit.
Career Highlights
Kagemoto is associated with Dainippon Pharmaceutical Company, Limited, where he has been able to apply his expertise in pharmaceutical research and development. His work has been instrumental in advancing methodologies for drug determination and analysis.
Collaborations
Kagemoto has collaborated with notable colleagues, including Noriyuki Sunahara and Shunsuke Naruto. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Akira Kagemoto's innovative contributions to the determination of valproic acid highlight his role as a significant inventor in the pharmaceutical field. His work not only advances scientific understanding but also has practical applications in medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
